Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of oral paclitaxel (Liporaxel) in GIST with low P-glycoprotein expression after failure of imatinib, sunitinib, and regorafenib
KCT0009438Phase 2Not yet recruiting
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in gastrointestinal stromal tumor (GIST), sponsored by Daehwa Pharmaceutical Co., Ltd. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
paclitaxel
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on KCT0009438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009438.